Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Oxford PharmaGenesis

Oxford PharmaGenesis is listed as a mid sized business research supplier in the Scientist.com network, with 1 site in 1 country.

View Oxford PharmaGenesis on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Mid sized business

Brand Communications

  • Patient-HCP Communication Aids Design and development of tools (visuals, guides, devices) that facilitate clear, accurate, and empathetic two-way dialogue between patients and their healthcare providers.

Clinical Consulting

  • Biostatistics Consulting Apply statistical theory and mathematical principals to research
  • Patient Advocacy Help patients communicate with their healthcare providers so they get the information they need to make decisions about their health care.

Clinical Trials

  • Diversity and Inclusion Consulting For Trials Diversity and inclusion consulting for trials involves providing expert guidance to ensure that clinical trials are designed and conducted in ways that include diverse populations and address barriers...
  • Investigator Meeting Planning & Execution Investigator planning and meetings ensure that there is proper communication and reliability during a clinical trial. Allows for efficient work flow.
  • Protocol Optimization via AI/ML Using of artificial intelligence and machine learning techniques to enhance and streamline experimental protocols or operational procedures for improved efficiency, accuracy, and outcomes.
  • Regulatory Affairs Consulting Receive assistance ensuring compliance with regulatory requirements.
  • Statistical Analysis Planning Technical and detailed elaboration of the principal features of the analysis described in the protocol, and includes detailed procedures for executing the statistical analysis of the primary and secondary variables...

Creative

  • Case Studies Recruit research participants with a behavioral condition to receive either an investigational behavioral intervention or a behavioral intervention in clinical use.
  • Infographic Create a quick visual representation of information, data or knowledge.

Data Science/Bioinformatics

  • Graph-Based Patient Journey Analysis Graph-based patient journey analysis is a method of visualizing and analyzing the pathways patients take through healthcare systems using graph structures, enabling insights into patient experiences, care patterns...
  • RWE/HEOR Machine Learning/AI Complex analytical approaches to find patterns and make predictions in RWE/HEOR projects
Show all 122 services 110 more

Drug Development

  • Bioinformatics Consulting Consulting Services for the science of collecting and analyzing complex biological data
  • Consulting Services Work with consultants who provide expert advice in various areas of research and technology.

HEOR

  • Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
  • Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
  • Cost Effectiveness Analysis Compare alternative treatments that lead to similar health outcomes.
  • Decision Analytic Modeling Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
  • Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
  • Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
Show all 7 in HEOR 1 more
  • Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.

Market Access

  • Academy of Managed Care Pharmacy (AMCP) Dossier Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...
  • Communication & Advertisement Distribution of a range of materials, through various communication channels, to highlight a message containing scientific-related topics
  • Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
  • Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
  • Health Technology Assessment (HTA) Preparation/Strategy Dossier Development Perform evidence preparation and/or create strategies for the systematic evaluation of the properties, effects, and/or impacts of health care technology.
  • Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...
Show all 13 in Market Access 7 more
  • Market Access - HTA Landscape Assessment Conduct a HTA landscape assessment to evaluate the direct and indirect impact of health technology on a specific region.
  • Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
  • Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
  • Payer Toolkit Communicate product value to payers utilizing digital and mobile technology (For example, Payer-Facing iPad Models).
  • Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
  • Value Based Agreements or Outcomes-Based Contracts Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
  • Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...

Medical Communications

  • Abstracts Request services related to the writing and review of abstracts
  • Advisory Boards Logistical and content support for organizing panels of external experts to gather critical strategic insights and feedback on therapeutic and product development plans.
  • All Medical Meeting Materials and Content End-to-end service providing slide decks, handouts, training guides, and logistics required to run an internal or external medical meeting successfully.
  • Animated Content Development of diverse visual, interactive digital assets like infographics, data visualizations, and short animations to explain complex medical and scientific concepts simply.
  • Communication Plan Communications plan enables organizations and corporations to effectively deliver information to appropriate stakeholders and customers.
  • Competitive Intelligence Develop a coordinated competitive intelligence program which contains a systematic collection and analysis of information from multiple sources about a specific business's industry.
Show all 60 in Medical Communications 54 more
  • Congress Assets Development of all visual, printed, and digital materials needed for a medical congress, including posters, booth graphics, and digital screens.
  • Congress Listening/Insights Report Systematic collection, analysis, and summary of key discussions, scientific trends, competitor movements, and data presented at major medical congresses.
  • Congress Planning Comprehensive logistical and content management for a company's participation in major medical conferences, including booth design, abstract submission, and staff briefing.
  • Consensus reports Develop and submit a report that is a comprehensive examination by an expert panel of a scientific or medical issue.
  • Creation of Non promotional Education/Awareness Content Development of scientifically rigorous, balanced materials (like disease state primers or journal clubs) aimed purely at enhancing clinical understanding, not driving product use.
  • Data Visualization Visualize data collected from clinical trials and/or clinical research.
  • Development of non promotional Medical Education Plan Creation of a strategic, compliant framework outlining educational needs, target audiences, content objectives, and tactical deployment of medical materials without promoting a product.
  • Disease or Drug-Related Literature Curation, development, and compliant distribution of written materials (e.g., abstracts, manuscripts, summaries) related to a specific illness or medicinal product.
  • Educational Content Development Comprehensive development of diverse, multi-channel content assets that offer education and information about a specific therapeutic area or medicinal product.
  • Educational Impact Analysis Measurement and evaluation of non-promotional activities to determine the change in healthcare professionals' knowledge, attitude, or behavior resulting from the education.
  • eLearning Modules Development Development of interactive, self-paced digital courses that allow learners (internal staff or external HCPs) to master scientific content or therapeutic knowledge remotely.
  • Expertise in Adult Learning Principles Applying instructional design methods (like andragogy) to training and educational materials to maximize retention, application, and skill development for mature learners.
  • Faculty and/or Steering Committee Management Oversight and compliant coordination of expert groups involved in clinical trials, publication steering, or educational program development.
  • Gap Analysis Compare the actual performance of an organization or corporation with potential or desired performance, as ways to effectively analyze resource management or allocation.
  • HEOR/Value Publications Writing and submission of manuscripts and abstracts focusing on Health Economics and Outcomes Research (HEOR) data, which demonstrate the economic and value proposition of a therapy.
  • Internal Evidence Providing organized access and summaries of unpublished company-held data (e.g., clinical study reports) to internal medical and scientific teams.
  • Investigational Medicinal Product Dossier (IMPD) and Investigational New Drug (IND) Dossier Develop and submit Investigational Medicinal Product Dossier (IMPD) and Investigational New Drug (IND) Dossier
  • KEE Identification, Mapping & Engagement Planning Systematic process to identify, categorize, and strategically plan outreach to Key External Experts (KEEs) based on their influence, specialization, and research activity.
  • KOL Engagement & Management Building and maintaining compliant, value-driven relationships with Key Opinion Leaders (KOLs) to collaborate on scientific exchange and clinical education initiatives.
  • Landscape Analysis Find a cohesive and consistent view of your main organization. Develop initiatives in analyzed areas of operations and analyze chosen key aspects of them.
  • Layperson Clinical Trial Result Dissemination Layperson clinical trial result dissemination involves translating complex clinical trial findings into clear, accessible language so that non-experts can easily understand the outcomes and implications.
  • Manuscript Co-Authorship and Publications Planning Manuscript co-authorship and publications planning involve collaborating among researchers to write, organize, and strategize the submission and publication of scientific findings in academic journals, ensuring proper...
  • Mechanism of Disease (MOD) & Mechanism of Action (MOA) Videos Production of dynamic, scientifically accurate animated videos illustrating how a disease develops (MOD) and how a drug therapeutically affects the body (MOA).
  • Medical Academy Training Developing structured, curriculum-based training programs for internal medical affairs teams, focusing on scientific, therapeutic, and compliance knowledge mastery.
  • Medical Affairs Services for non-promotional scientific exchange, supporting the dissemination of accurate medical data and the development of educational content.
  • Medical Affairs Dossiers Develop medical affairs dossiers such as Global Value Dossiers or AMCP Dossiers.
  • Medical Communications Master Class Design and execution of in-depth, high-level educational sessions led by top Key Opinion Leaders (KOLs) focusing on advanced clinical or scientific topics.
  • Medical Education & Training Creation, development, production and dissemination (internally and externally) of non-promotional disease and treatment-related materials that educate specifically with medicine or healthcare.
  • Medical Infographics Creation of visually engaging, concise graphic summaries to rapidly convey complex clinical data, scientific concepts, or statistical results.
  • Medical Information Encompasses both regulatory and non-regulatory medical writing. This function delivers balanced, evidence-based responses for reactive medical inquiries and develops strategic, proactive medical information platforms...
  • Medical Information Booth Materials Creation of scientifically accurate, pre-approved documents and visuals for staff to use when answering unsolicited questions at congress exhibition booths.
  • Medical Literature Reviews Systematic searching, appraisal, and synthesis of published scientific literature to generate evidence-based reports on a specific topic, disease, or treatment.
  • Medical Publications Make clear and accurate presentations of scientific and technical data.
  • Medical Q&As Developing pre-approved, standardized documents containing accurate, balanced answers to anticipated scientific inquiries about a product or disease.
  • Medical Standard A specialized governance and compliance function responsible for the final technical and regulatory certification of all scientific materials.
  • Medical Website/Hub Design Design and maintenance of a compliant online portal serving as a repository for scientific publications, educational resources, and medical information for external stakeholders.
  • Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.
  • Meeting and Events A gathering of people with a shared purpose, often for business or organizational goals
  • New Product/Indication Launch Planning Strategic development of the medical affairs communication road map and activities necessary to support the successful introduction of a new therapy or approved use.
  • Other Medical Affairs Videos Develop and design Medical Affair videos that are explainer videos and or augmented/virtual reality experiences.
  • Patient Advocacy Group Engagement Compliant collaboration and information sharing with non-profit organizations that represent patient communities to understand their needs and provide education.
  • Postcast Production Production of audio content featuring expert interviews, clinical data reviews, or scientific discussions, providing easily digestible learning for healthcare professionals (HCPs).
  • Poster Design and Development Design and Develop Posters for Poster Symposiums and conferences to effectively convey science information.
  • Poster Symposia, Summits, Product Theaters, etc. Support Comprehensive planning and execution support for organized, large-scale medical meetings and events used to present and discuss clinical data and research.
  • Proactive and Reactive Medical Affairs Assets Development of both planned educational materials and responsive documents used by Medical Affairs to address scientific information gaps.
  • Publication Writing Create further publication documents. Investigational device exemptions (IDEs) BLAs, MAA, PMA, eCTDs, informed consents, CMC and manufacturing reports, orphan drug designations (ODD), briefing books.
  • Publications Plan Development & Management Strategic planning and oversight of all research dissemination activities, including outlining target journals, timelines, authors, and compliance for clinical data publications.
  • Regulatory Submissions and Compliance Draft, format, and submit documents to Pharmaceutical approval agencies according to documentation and guidelines. This includes documents such as NDAs, INDs, SUSARs, AE reporting, RMPs, and PSURS.
  • Review Article/ Submission Drafting and managing the process of submitting an objective, comprehensive summary of the current literature on a disease or treatment area to a peer-reviewed journal.
  • Scientific Platform Develop a rigorous approach to creating a core story (grounded in the scientific literature) for a product. This involves identifying core concepts that address disease states, clinical needs, and product-related...
  • Scientific Positioning Strategic development of the evidence-based argument that defines how a drug or therapy is distinct, superior, or beneficial relative to competitors in the market.
  • Scientific Training Solutions Developing comprehensive educational programs and materials to ensure internal teams, field medical staff, or external partners are fluent in the therapeutic area and product data.
  • Strategic Medical Communication Development & Planning High-level planning to define the core scientific messages and the tactical strategy needed to effectively convey clinical data to key stakeholders over time.
  • Therapy Area Disease Insights Report Creation of a comprehensive analysis of the current scientific, clinical, and competitive landscape within a specific therapeutic area.

Medical/Commercial

  • Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.

Old Category HEOR, RWE, Market Access

  • Patient-Reported Outcome Studies Get self-reported information regarding the personal health status of an individual.

Primary Market Research

  • Competitive Landscape Research Maps competitor products, positioning, trial activity, and perception among stakeholders. Delivers inputs for SWOT analysis and differentiation strategy.
  • Journey Mapping (Patient, HCP, Payer) Visual representation of stakeholder experiences across disease or treatment timelines. Identifies pain points, decision triggers, and opportunities for engagement or support.
  • Market Opportunity Assessments Quantifies addressable market size, unmet needs, and competitive landscape. Supports go/no-go decisions and commercial forecasting.
  • Payer and HTA Expectations Research Engages payers and HTA bodies to uncover evidence needs, pricing thresholds, and access drivers. Informs clinical and economic evidence generation planning.
  • Positioning and Value Proposition Testing Tests various positioning statements and value messages with target audiences. Refines messaging to maximize resonance and differentiation.
  • Product Landscape and Unmet Needs Reports Synthesizes secondary data and expert input into landscape maps and gap analyses. Informs asset development and positioning.
Show all 7 in Primary Market Research 1 more
  • Strategic Recommendations for Brand Teams Delivers synthesized insights and data-driven strategic guidance to commercial teams. Supports brand planning and lifecycle management.

REACH Services

  • Dossier Prep. and Consultancy Assistance with creation of a regulatory document that contains all the Clinical, non-clinical, and CMC information of a pharmaceutical product to be approved, registered, or marketed within a specific country.

Real World Evidence & Data

  • Meta-Analysis Use quantitative statistical approaches to pool results across multiple studies to improve power or resolve uncertainty; may be used in conjunction with a systematic review.
  • Patient Reported Outcomes (PRO) Databases Database or collection of data related to health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician or anyone else.
  • Predictive Analytics Variety of statistical techniques from data mining, predictive modeling, and machine learning, that analyze current and historical facts to make predictions about future or otherwise unknown events.
  • Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
  • Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
  • Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
Show all 13 in Real World Evidence & Data 7 more
  • Registries - Disease Database containing, through utilizing observational research methods, standardized data about patients who have the same disease.
  • Registries - Patient Database containing, through utilizing observational research methods, standardized data about patients who have the same condition, disease, or exposure and is used to evaluate an outcome
  • RWD - Oncology Data from oncology patients, can include clinical treatment, diagnosis, among others.
  • RWD - Rare Diseases Data from patients with rare diseases, can include clinical treatment, diagnosis, among others.
  • RWD - Wearables Data gathered from sources including pedometers, mobile devices, smart watches, among others.
  • RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.
  • Secondary Real World Evidence Analyze clinical trial data.

Regulatory Affairs

  • Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.

Scientific Data Services

  • Machine Learning/ AI Predict and model an outcome (e.g. disease progression) based on input variables (i.e. features.)
  • Scientific Data Visualization Exploration and reporting of data by means of graphs and plots.

Other services

  • Observational Research Gain valuable insights into the association between a drug treatment and its outcomes such as long-term effectiveness and safety.
  • Rare Diseases Recruitment of volunteers or study participants who have a rare disease, or specifically in the "U.S.when a chronic and enervating condition afflicts fewer than 200,000 people combined, and in the EU, when it affects...

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • United Kingdom Oxford 1 site

Source: Scientist.com supplier network (site locations)

Get the Oxford PharmaGenesis report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Oxford PharmaGenesis on Scientist.com

For prices, more details, or to contact Oxford PharmaGenesis, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.